Švedija - švedų - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - metforminhydroklorid; sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 50 mg/1000 mg - natriumlaurilsulfat hjälpämne; sitagliptinhydrokloridmonohydrat 56,688 mg aktiv substans; metforminhydroklorid 1000 mg aktiv substans

Europos Sąjunga - švedų - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - metforminhydroklorid; sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 50 mg/850 mg - natriumlaurilsulfat hjälpämne; metforminhydroklorid 850 mg aktiv substans; sitagliptinhydrokloridmonohydrat 54,475 mg aktiv substans

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - metforminhydroklorid; sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 50 mg/1000 mg - metforminhydroklorid 1000 mg aktiv substans; sitagliptinhydrokloridmonohydrat 54,475 mg aktiv substans; natriumlaurilsulfat hjälpämne

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

reddy holding gmbh - metforminhydroklorid; sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 50 mg/850 mg - natriumlaurilsulfat hjälpämne; metforminhydroklorid 850 mg aktiv substans; sitagliptinhydrokloridmonohydrat 56,69 mg aktiv substans

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

reddy holding gmbh - metforminhydroklorid; sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 50 mg/1000 mg - sitagliptinhydrokloridmonohydrat 56,69 mg aktiv substans; metforminhydroklorid 1000 mg aktiv substans; natriumlaurilsulfat hjälpämne

Europos Sąjunga - švedų - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

teva b.v. - metforminhydroklorid - filmdragerad tablett - 500 mg - metforminhydroklorid 500 mg aktiv substans

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

teva b.v. - metforminhydroklorid - filmdragerad tablett - 1000 mg - metforminhydroklorid 1000 mg aktiv substans

Švedija - švedų - Läkemedelsverket (Medical Products Agency)

teva b.v. - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans